Vascular endothelial growth factor expression in renal cell carcinoma

Introduction: Renal cell carcinoma (RCC) is the most common renal malignancies. In advanced stage, it is highly resistant to systemic therapies. RCC is a highly vascular tumour and angiogenesis pathway has been postulated in its carcinogenesis. Novel drug targeting Vascular Endothelial Growth Factor...

Full description

Bibliographic Details
Main Authors: Mohtarrudin, Norhafizah, Mhd Nasir, Mhd Shidee, Abu Bakar, Rosila, Koey, Peng Mun, Osman, Malina, Mohd Yusoff, Suryati
Format: Article
Language:English
Published: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2018
Online Access:http://psasir.upm.edu.my/id/eprint/66173/1/2018121312081805_MJMHS_December_2018.pdf
_version_ 1825933082450984960
author Mohtarrudin, Norhafizah
Mhd Nasir, Mhd Shidee
Abu Bakar, Rosila
Koey, Peng Mun
Osman, Malina
Mohd Yusoff, Suryati
author_facet Mohtarrudin, Norhafizah
Mhd Nasir, Mhd Shidee
Abu Bakar, Rosila
Koey, Peng Mun
Osman, Malina
Mohd Yusoff, Suryati
author_sort Mohtarrudin, Norhafizah
collection UPM
description Introduction: Renal cell carcinoma (RCC) is the most common renal malignancies. In advanced stage, it is highly resistant to systemic therapies. RCC is a highly vascular tumour and angiogenesis pathway has been postulated in its carcinogenesis. Novel drug targeting Vascular Endothelial Growth Factor (VEGF) and advanced surgical interventions have shown to increase the overall patients’ survival. In this study, we evaluated the VEGF expression of RCC using immunohistochemistry technique and its potential correlation with the tumour grades. Methods: 40 RCC cases that underwent nephrectomy were selected. The archived samples of formalin fixed, paraffin-embedded (FFPE) were retrieved. The tumour tissue blocks were carefully chosen, sectioned and stained with VEGF using immunohistochemistry technique. The intensity of VEGF expression was scored as 0 (negative), 1+ (weak), 2+ (moderate) or 3+ (strong). Results: Majority of the RCC cases were male, with male to female ratio of 2.1:1. Mean patient age was 56.2 years (age ranged between 16 to 74 years). Most of the cases were Malays (42.5 %). VEGF was expressed in 36 (90%) of RCC cases. Among the 36 cases that were immunopositive, 8 (16.7%) were grade 1, 20 (55.6%) grade 2 and 8 (16.7%) grade 3. There was no significant association between VEGF expressions score and grades of RCC (p=0.39). Conclusion: VEGF was expressed in majority of RCC cases although there was no significant association with tumour grades.
first_indexed 2024-03-06T09:51:50Z
format Article
id upm.eprints-66173
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T09:51:50Z
publishDate 2018
publisher Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
record_format dspace
spelling upm.eprints-661732019-02-11T03:59:32Z http://psasir.upm.edu.my/id/eprint/66173/ Vascular endothelial growth factor expression in renal cell carcinoma Mohtarrudin, Norhafizah Mhd Nasir, Mhd Shidee Abu Bakar, Rosila Koey, Peng Mun Osman, Malina Mohd Yusoff, Suryati Introduction: Renal cell carcinoma (RCC) is the most common renal malignancies. In advanced stage, it is highly resistant to systemic therapies. RCC is a highly vascular tumour and angiogenesis pathway has been postulated in its carcinogenesis. Novel drug targeting Vascular Endothelial Growth Factor (VEGF) and advanced surgical interventions have shown to increase the overall patients’ survival. In this study, we evaluated the VEGF expression of RCC using immunohistochemistry technique and its potential correlation with the tumour grades. Methods: 40 RCC cases that underwent nephrectomy were selected. The archived samples of formalin fixed, paraffin-embedded (FFPE) were retrieved. The tumour tissue blocks were carefully chosen, sectioned and stained with VEGF using immunohistochemistry technique. The intensity of VEGF expression was scored as 0 (negative), 1+ (weak), 2+ (moderate) or 3+ (strong). Results: Majority of the RCC cases were male, with male to female ratio of 2.1:1. Mean patient age was 56.2 years (age ranged between 16 to 74 years). Most of the cases were Malays (42.5 %). VEGF was expressed in 36 (90%) of RCC cases. Among the 36 cases that were immunopositive, 8 (16.7%) were grade 1, 20 (55.6%) grade 2 and 8 (16.7%) grade 3. There was no significant association between VEGF expressions score and grades of RCC (p=0.39). Conclusion: VEGF was expressed in majority of RCC cases although there was no significant association with tumour grades. Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2018 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/66173/1/2018121312081805_MJMHS_December_2018.pdf Mohtarrudin, Norhafizah and Mhd Nasir, Mhd Shidee and Abu Bakar, Rosila and Koey, Peng Mun and Osman, Malina and Mohd Yusoff, Suryati (2018) Vascular endothelial growth factor expression in renal cell carcinoma. Malaysian Journal of Medicine and Health Sciences, 14 (SP3). pp. 36-40. ISSN 1675-8544; ESSN: 2636-9346 http://www.medic.upm.edu.my/upload/dokumen/2018121312081805_MJMHS_December_2018.pdf
spellingShingle Mohtarrudin, Norhafizah
Mhd Nasir, Mhd Shidee
Abu Bakar, Rosila
Koey, Peng Mun
Osman, Malina
Mohd Yusoff, Suryati
Vascular endothelial growth factor expression in renal cell carcinoma
title Vascular endothelial growth factor expression in renal cell carcinoma
title_full Vascular endothelial growth factor expression in renal cell carcinoma
title_fullStr Vascular endothelial growth factor expression in renal cell carcinoma
title_full_unstemmed Vascular endothelial growth factor expression in renal cell carcinoma
title_short Vascular endothelial growth factor expression in renal cell carcinoma
title_sort vascular endothelial growth factor expression in renal cell carcinoma
url http://psasir.upm.edu.my/id/eprint/66173/1/2018121312081805_MJMHS_December_2018.pdf
work_keys_str_mv AT mohtarrudinnorhafizah vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma
AT mhdnasirmhdshidee vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma
AT abubakarrosila vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma
AT koeypengmun vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma
AT osmanmalina vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma
AT mohdyusoffsuryati vascularendothelialgrowthfactorexpressioninrenalcellcarcinoma